Lek PharmaTech ups capital by $3m

Lek PharmaTech company, based in Targu Mures, will increase its share capital by 100.1 billion ROL (about three million dollars), from 93.2 billion ROL to 193.3 billion ROL, through a contribution in kind by its sole shareholder, the Slovenian Lek Pharmaceuticals. The capital inflow will support further investment in the antibiotics unit in Targu-Mures, the company’s representatives say. Lek PharmaTech has invested over 12 million dollars in production lines, labs, warehouses, as well as in an administrative building. The Slovenian company has invested above 30 million dollars in Romania since 2001, with the group already owning an antibiotics plant in Targu-Mures. ZF